| Three-dimensional structure of the KChIP1–Kv4. 3 T1 complex reveals a cross-shaped octamer M Pioletti, F Findeisen, GL Hura, DL Minor Jr Nature structural & molecular biology 13 (11), 987-995, 2006 | 188 | 2006 |
| Structure of a prokaryotic sodium channel pore reveals essential gating elements and an outer ion binding site common to eukaryotic channels D Shaya, F Findeisen, F Abderemane-Ali, C Arrigoni, S Wong, SR Nurva, ... Journal of molecular biology 426 (2), 467-483, 2014 | 158 | 2014 |
| The structure of a pH-sensing mycobacterial adenylyl cyclase holoenzyme I Tews, F Findeisen, I Sinning, A Schultz, JE Schultz, JU Linder Science 308 (5724), 1020-1023, 2005 | 143 | 2005 |
| Progress in the structural understanding of voltage-gated calcium channel (CaV) function and modulation F Findeisen, DL Minor, Jr Channels 4 (6), 459-474, 2010 | 135 | 2010 |
| Multiple C‐terminal tail Ca2+/CaMs regulate CaV1.2 function but do not mediate channel dimerization EY Kim, CH Rumpf, F Van Petegem, RJ Arant, F Findeisen, ES Cooley, ... The EMBO journal 29 (23), 3924-3938, 2010 | 87 | 2010 |
| Disruption of the IS6-AID linker affects voltage-gated calcium channel inactivation and facilitation F Findeisen, DL Minor Jr Journal of General Physiology 133 (3), 327-343, 2009 | 82 | 2009 |
| Unfolding of a temperature-sensitive domain controls voltage-gated channel activation C Arrigoni, A Rohaim, D Shaya, F Findeisen, RA Stein, SR Nurva, ... Cell 164 (5), 922-936, 2016 | 73 | 2016 |
| Structural basis for the differential effects of CaBP1 and calmodulin on CaV1. 2 calcium-dependent inactivation F Findeisen, DL Minor Structure 18 (12), 1617-1631, 2010 | 67 | 2010 |
| Apo states of calmodulin and CaBP1 control CaV1 voltage-gated calcium channel function through direct competition for the IQ domain F Findeisen, CH Rumpf, DL Minor Jr Journal of molecular biology 425 (17), 3217-3234, 2013 | 61 | 2013 |
| A selectivity filter gate controls voltage-gated calcium channel calcium-dependent inactivation F Abderemane-Ali, F Findeisen, ND Rossen, DL Minor Neuron 101 (6), 1134-1149. e3, 2019 | 47 | 2019 |
| Stapled Voltage-Gated Calcium Channel (CaV) α-Interaction Domain (AID) Peptides Act As Selective Protein–Protein Interaction Inhibitors of CaV Function F Findeisen, M Campiglio, H Jo, F Abderemane-Ali, CH Rumpf, L Pope, ... ACS chemical neuroscience 8 (6), 1313-1326, 2017 | 41 | 2017 |
| Calmodulin overexpression does not alter Cav1. 2 function or oligomerization state F Findeisen, A Tolia, R Arant, E Young Kim, E Isacoff, DL Minor, Jr Channels 5 (4), 320-324, 2011 | 20 | 2011 |
| The structure of the regulatory domain of the adenylyl cyclase Rv1264 from Mycobacterium tuberculosis with bound oleic acid F Findeisen, JU Linder, A Schultz, JE Schultz, B Brügger, F Wieland, ... Journal of molecular biology 369 (5), 1282-1295, 2007 | 19 | 2007 |
| Calmodulin interactions with Cav1 and Cav2 voltage-gated calcium channel IQ domains EY Kim, F Findeisen, DL Minor Handbook of Metalloproteins, Messerschmidt A, ed.(John Wiley;).[Google Scholar], 2010 | 7 | 2010 |
| Quaternary structure independent folding of voltage-gated ion channel pore domain subunits C Arrigoni, M Lolicato, D Shaya, A Rohaim, F Findeisen, LK Fong, ... Nature structural & molecular biology 29 (6), 537-548, 2022 | 6 | 2022 |
| Highly selective anti-CCR8 antibody-mediated depletion of regulatory T cells leads to potent antitumor activity alone and in combination with anti-PD-1 in preclinical models R Lan, A Jhatakia, J Campbell, N Siemers, K Lu, M Nasser, T Grigoriev, ... Cancer Research 80 (16_Supplement), 6694-6694, 2020 | 6 | 2020 |
| Anti-ccr8 antibodies for treating cancer RYZ Lan, OA Adelakun, I Barman, J Campbell, SJJZ Diong, F Findeisen, ... US Patent App. 17/914,257, 2023 | 1 | 2023 |
| Preclinical characterization of BMS-986288, a novel non-fucosylated (NF) anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) Probody® therapeutic A Jhatakia, M Nasser, A Mukhopadhyay, K Kang, C Newsome, N Gupta, ... Cancer Research 84 (6_Supplement), 1351-1351, 2024 | | 2024 |
| Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGIT SJJ Diong, A Jashnani, AW Drake, C Bee, F Findeisen, G Dollinger, ... Mabs 15 (1), 2253788, 2023 | | 2023 |
| Anticuerpos anti-ccr8 para el tratamiento del cancer RYZ Lan, OA Adelakun, I Barman, JR Campbell, SJZ Diong, F Findeisen, ... | | 2023 |
